PortfoliosLab logo
LifeMD, Inc. (LFMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US53216B1044

CUSIP

53216B104

IPO Date

Jan 2, 2001

Highlights

Market Cap

$336.16M

EPS (TTM)

-$0.53

Total Revenue (TTM)

$155.19M

Gross Profit (TTM)

$146.11M

EBITDA (TTM)

-$2.58M

Year Range

$3.99 - $9.87

Target Price

$12.00

Short %

16.07%

Short Ratio

7.67

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in LifeMD, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%7,000.00%December2025FebruaryMarchAprilMay
6,176.92%
472.92%
LFMD (LifeMD, Inc.)
Benchmark (^GSPC)

Returns By Period

LifeMD, Inc. (LFMD) returned 64.85% year-to-date (YTD) and -33.82% over the past 12 months. Over the past 10 years, LFMD delivered an annualized return of 32.30%, outperforming the S&P 500 benchmark at 10.43%.


LFMD

YTD

64.85%

1M

69.29%

6M

59.06%

1Y

-33.82%

5Y*

39.55%

10Y*

32.30%

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of LFMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202512.53%-5.57%3.42%35.29%10.87%64.85%
2024-32.57%42.40%29.15%16.05%-30.85%-16.85%3.94%-26.93%0.58%-22.14%61.52%-24.89%-40.29%
20232.06%-10.10%-4.49%-2.35%17.47%123.08%8.97%-18.57%61.92%0.16%23.00%7.66%327.32%
2022-5.68%1.92%-5.11%-36.83%0.90%-9.33%21.57%3.63%-23.35%11.17%10.96%-20.16%-49.87%
2021218.84%5.38%-27.89%-38.62%32.65%-8.54%-16.72%-19.67%-21.19%-19.65%-18.44%-4.91%-40.74%
202016.67%-7.14%61.54%28.57%7.41%3.45%213.33%43.62%22.22%-27.39%48.58%-26.63%988.33%
201921.43%-17.65%7.14%20.00%-22.22%-21.43%27.27%-7.14%30.77%-0.00%0.00%-29.41%-14.29%
2018-17.65%-3.57%3.70%-0.00%-17.86%-4.35%9.09%16.67%-28.57%-0.00%0.00%-30.00%-58.82%
2017-7.69%16.67%78.57%-14.00%-16.28%-16.67%40.00%-11.90%16.22%-0.00%-9.30%-12.82%30.77%
201625.00%66.67%20.00%-20.00%20.83%-10.34%-0.00%-7.69%8.33%3.85%7.41%-10.34%116.67%
201580.00%-5.56%5.88%-22.22%-28.57%-10.00%44.44%-15.38%-54.55%160.00%-46.15%71.43%20.00%
20143.85%-7.41%0.00%-24.00%-21.05%-6.67%-14.29%-8.33%18.18%-15.38%27.27%-28.57%-61.54%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LFMD is 36, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LFMD is 3636
Overall Rank
The Sharpe Ratio Rank of LFMD is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 4040
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 4040
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 2727
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 3838
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for LifeMD, Inc. (LFMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current LifeMD, Inc. Sharpe ratio is -0.34. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of LifeMD, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.34
0.48
LFMD (LifeMD, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


LifeMD, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-73.29%
-7.82%
LFMD (LifeMD, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the LifeMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LifeMD, Inc. was 96.24%, occurring on Mar 17, 2023. The portfolio has not yet recovered.

The current LifeMD, Inc. drawdown is 73.29%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.24%Feb 18, 2021524Mar 17, 2023
-87.8%Dec 10, 2013455Sep 30, 2015358Mar 3, 2017813
-87.34%Mar 7, 2017580Jun 25, 2019263Jul 10, 2020843
-81.05%Aug 4, 2003366Dec 29, 200553May 3, 2006419
-81.03%May 8, 2006204Oct 1, 200739Jan 29, 2008243

Volatility

Volatility Chart

The current LifeMD, Inc. volatility is 40.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
40.39%
11.21%
LFMD (LifeMD, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of LifeMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of LifeMD, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 50.0% positive surprise.


-2.50-2.00-1.50-1.00-0.500.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
0.21
0.14
Actual
Estimate

Valuation

The Valuation section provides an overview of how LifeMD, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LFMD relative to other companies in the Pharmaceutical Retailers industry. Currently, LFMD has a P/S ratio of 1.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LFMD in comparison with other companies in the Pharmaceutical Retailers industry. Currently, LFMD has a P/B value of 107.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items